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Abstract
Human umbilical cord blood (hUCB) has been proposed to contain not only haematopoietic stem cells, but also a rare
pluripotent embryonic-like stem cell (ELSc) population that is negative for hematopoietic markers (Lin2CD452) and
expresses markers typical of pluripotent cells. The aim of this work was to isolate, characterise and expand this ELSc fraction
from hUCB, as it may provide a valuable cell source for regenerative medicine applications. We found that we could indeed
isolate a Lin2CD452 population of small cells (3–10 mm diameter) with a high nucleus to cytoplasm ratio that expressed the
stem cell markers CD34 and CXCR4. However, in contrast to some previous reports, this fraction was not positive for CD133.
Furthermore, although these cells expressed transcripts typical of pluripotent cells, such as SOX2, OCT3/4, and NANOG, they
were not able to proliferate in any of the culture media known to support stem cell growth that we tested. Further analysis
of the Lin2CD452 population by flow cytometry showed the presence of a Lin2CD452Nestin+ population that were also
positive for CD34 (20%) but negative for CXCR4. These data suggest that the Lin2CD452 stem cell fraction present in the
cord blood represents a small heterogeneous population with phenotypic characteristics of stem cells, including a
Lin2CD452Nestin+ population not previously described. This study also suggests that heterogeneity within the Lin2CD452
cell fraction is the likely explanation for differences in the hUCB cell populations described by different groups that were
isolated using different methods. These populations have been widely called ‘‘embryonic-like stem cell’’ on the basis of their
phenotypical similarity to embryonic stem cells. However, the fact they do not seem to be able to self-renew casts some
doubt on their identity, and warns against defining them as ‘‘embryonic-like stem cell’’ at this stage.
Citation: Alvarez-Gonzalez C, Duggleby R, Vagaska B, Querol S, Gomez SG, et al. (2013) Cord Blood Lin2CD452 Embryonic-Like Stem Cells Are a Heterogeneous
Population That Lack Self-Renewal Capacity. PLoS ONE 8(6): e67968. doi:10.1371/journal.pone.0067968
Editor: Zoran Ivanovic, French Blood Institute, France
Received April 7, 2013; Accepted May 24, 2013; Published June 28, 2013
Copyright:  2013 Alvarez Gonzalez et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The authors thank the Anthony Nolan and the Great Ormond Street Hospital Charity for financial support. Cesar Alvarez-Gonzalez is a fellowship from
Consejo Nacional de Ciencia y Tecnologia (CONACyT) and Instituto Jaliscience de la Juventud (IJJ); Mexico. The funders had no role in study design, data collection
and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: a.madrigal@ucl.ac.uk
Introduction
Human umbilical cord blood stem cells (HUCBSC) are
potentially a very important source of stem cells for tissue repair,
as their use would circumvent the ethical issues involved with
embryonic stem cells. Furthermore, HUCBSC have already been
extensively used for treating many haematological related disor-
ders, hence they are believed to be safe [1,2]. Whereas there are a
number of reports suggesting the human umbilical cord blood
(hUCB) can give raise to different lineages, the issue of their origin
and of the existence of a truly pluripotent population with the
hUCB has been a matter of debate. Recently, much work has
focused on the characterization of HUCBSC and their potential to
differentiate into different lineages, including neural cell types [1].
From the studies aimed at characterizing population(s) of putative
stem cells present in the hUCB, the population of stem cells
lacking expression of CD45/leukocyte common antigen (LCA) is
of particular interest [3,4,5].
Relatively little information on this CD45 negative (CD452)
population is currently available. It has been reported to also lack
expression of mature lineage (Lin) markers (CD2, CD3, CD14,
CD16, CD19, and CD56), but to express several stem cell
markers, such as CD34, CD133, and CXCR4. In addition, it
appears to express transcripts typical of pluripotent stem cells, such
as SOX2, OCT3/4, and NANOG [4]. CD452 populations have
been isolated from bone marrow and hUCB using a range of
different protocols, characterized using different parameters and
the resulting cells have been assigned several different names
[6,7,8,9,10,11,12]. These include: very small embryonic-like stem
cells (VSELs) [6], cord-blood-derived embryonic-like stem cells
(CBEs) [7], multipotent adult progenitor cells (MAPC) [8], serum
deprivation-induced bone marrow stem cells (SD-BMSC) [9],
marrow-isolated adult multi-lineage inducible (MIAMI) cells [10],
multipotent adult stem cells [11], and unrestricted somatic stem
cells (USSCs) [13]. While some of the features of the CD452
population in hUCB reported by the different groups are the
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same, others differ, and the properties, function, and plasticity of
this cell population remain unclear.
The aim of this study was to further characterize the
Lin2CD452 population(s) present in the hUCB to clarify the
discrepancy in the features of this population reported in the
literature and assess their behaviour. The Lin2CD452 population
was isolated using a magnetic cell isolation method modified from
McGuckin et al. [3] from the cord blood nucleated cell fraction
purified either by red blood cell lysis or by density gradient
centrifugation. This excluded most of hematopoietic population
including the Haematopoietic Stem Cells (HSC). Analysis of the
Lin2CD452 population demonstrated the presence of different
subpopulations both in regard to cell size and stem cell marker
expression. Furthermore, although we could detect expression of
markers of pluripotency, such SOX2, OCT3/4, and NANOG, no
proliferation of these cells occurred under any of the culture
conditions tested. Therefore, the embryonic stem cell-like molec-
ular phenotype is not mirrored by self-renewing capability.
Altogether, our study does not support a significant presence of
embryonic stem cell-like cells in the hUCB, and suggests the
presence of a heterogeneous population within the Lin2CD452
cell fraction that can at least partly reconcile differences reported
in different studies.
Materials and Methods
Cell Sources
Whole cord blood from non-clinical standard units was supplied
by the Anthony Nolan Cell Therapy Centre (http://www.
anthonynolan.org/Healthcare-professionals/Cord-blood-services.
aspx) from consented mothers with healthy full-term pregnancies.
Total nucleated cells (TNCs) were prepared using two different
protocols. The first protocol involved lysis of red blood cells using
BD Pharm Lyse (Cat: 555899). Briefly, hUCB was centrifuged at
1000g to remove the cord plasma as reported by Bhartiya, D.,
et al. [5]. The pellet containing red blood cells (RBCs) and TNCs
was treated with lysing buffer (dilution 1:5) for 15 minutes at room
temperature (RT), in accordance with manufacturer instructions,
and centrifuged at 1000g for 10 minutes at RT (for detailed
protocol, see Methods S1). Cells were washed twice with
phosphate buffer saline (PBS, AccuGENEH Lonza Cat: 51226).
The second protocol involved the use of density gradient
centrifugation over Ficoll-PaqueTM PREMIUM (GE healthcare).
Cord blood mononuclear Cells (CBMCs) were isolated from the
interphase after gradient centrifugation (at 840g) over Ficoll-
PaqueTM PREMIUM and treated once with lysis buffer due to
residual RBCs. The pellet was washed twice with PBS,
resuspended, and centrifuged at 1000g to isolate the light-density
mononuclear cells.
A Human Neural Stem Cell (hNSC) line that was generated and
expanded [K. Pong, Nicholas, A. P., Subramanian, V., Thomp-
son, P. R., Ferretti, P. Peptidylarginine deiminase 3 - a novel early
mediator of calcium-induced death in human neural stem cells.
Unpublished data, submitted, 2013] as previously described [14]
was used as a positive control for Nestin, CD133, and Sox2.
A line of Mesenchymal Stem Cells (UC-MSC) from Wharton’s
jelly generated as described previously by Weiss et al [15] was used
in some experiments as a control for gene expression analysis.
Flow Cytometry
Flow cytometry analysis was carried out with a BD FACSCa-
libur TM. Data analysis was performed using FlowJo 6.4.7
software (Tree Start, Inc. 1997–2006). The monoclonal antibodies
used were: from BD Bioscience: Lineage Cocktail 1 (FITC; Cat:
340546), CD34 (APC; clone: 581), CXCR4 (also known as CD184
Cat: 555974, clone: 12G5), 7AAD (Cat: 51-68981E), CD41a
(FITC and APC; clone: HIP8), Oct3/4 (PerCP-Cy TM 5.5; clone:
40/Oct-3), Anti-Sox2 (Alexa Flour 488; clone: 245610), SSEA-4
(FITC and PE; clone:MC813-70), and Nestin (PE; clone:
25NESTIN); from eBioscience, CD45 (biotin; clone:HI30),
CD235a (biotin; clone: HIR2), Hematopoietic Lineage (FITC
including CD2, CD3, CD14, CD16, CD19, CD56, and CD235a;
Cat: 22-7778); from Miltenyi Biotec: CD45 (FITC, PE, PerCP,
and APC clone: 5B1); CD133 (PE and APC clone: 293C3), and
Table 1. Stem cell culture conditions used to expand the Lin2CD452 stem cells.
A B C D E
Medium DMEM/F-12 DMEM/F-12 DMEM/F-12 RHB-AH StemSpanH SFEM
FBS (10%) 3
Supplements
FGF2 (20ng/ml) 3 3 3 3 3
EGF (20ng/ml) 3 3 3
SCF (25ng/ml) 3
Flt3-L (25ng/ml) 3
B27 (1:50) 3
N2 (1:100) 3
L-Glut (1:100) 3 3 3
P/S (1:100) 3 3 3 3 3
BSA (10mcg/ml) 3
Heparin Sulfate (10mcg/ml) 3 3 3 3 3
Substrate
Laminin 3
Matrigel 3 3 3 3
doi:10.1371/journal.pone.0067968.t001
hUCB ELSc Are a Heterogeneous Population
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anti-biotin antibodies PE and APC (Bio3-18E7). For cell surface
labelling, cells were incubated with antibodies diluted in FACS
buffer (2.5% FBS in PBS 1x) for 10–15 minutes at 4uC (with the
exception of CXCR4 where the incubation was for 30 minutes)
and then washed twice with FACS buffer for 3–4 min. For
intracellular staining, cells were fixed with 4% paraformaldehyde
for 20 minutes at 4uC, permeabilized with Perm/Wash Buffer I
(BD, Cat: 557885) for 5 minutes at RT, and stained with SOX2,
OCT3/4, or Nestin for 30 minutes and washed twice for 3–4
minutes with FACS buffer. For negative controls cells were stained
using FACS buffer only.
Magnetic Cell Isolation
After removing the erythrocytes using either the lysis buffer or
the gradient centrifugation method, TNCs were centrifuged at
1000g for 10 minutes the pellet resuspended in MACS buffer (PBS
1x, 2mM EDTA, and 1% BSA) at 4uC, and cells incubated for 10
minutes at 4uC in the dark with the following biotin-conjugated
antibodies: from eBioscience: CD235a (HIR2), CD11b (ICRF44),
CD123 (6H6), CD45 (HI30); from AbD Serotec: CD61 (PM6/13).
Anti-Biotin MicroBead-conjugated antibodies (Miltenyi Biotec,
Cat: 130-090-485) were then added and incubated for 15 minutes
at 4uC in the dark. Finally the cells were passed through LD
magnetic columns (Miltenyi Biotec, Cat: 130-042-901) according
to the manufacturer instructions and the negative fraction (-F)
collected.
RT-PCR and qPRC
Three cords were pooled for magnetic cell isolation. Total RNA
was isolated from the cell pellet using RNeasy Mini Kit (Qiagen,
Cat: 74104) according to manufacturer’s instructions. cDNA was
prepared using D6N random hexamer (Applied Biosystem)
annealed at 80uC for 10 minutes followed by reverse transcription
using MMLV-Ez (200 U/ml) (Promega), MLV-RT buffer (5X)
(Promega), dNTP (0.2 mM) (Bioline), RNasin Ribonuclease
Inhibitor (2500 U/ml) (Promega) and RNase free water. cDNA
was amplified in a Veriti thermal cycler (Applied Biosystems,
Figure 1. Recovery, viability, and clonogenic potential of the Lin2CD452 population. (A) The box plots show the percentage of cells
recovered after magnetic isolation using lysing buffer (Ly) or Ficoll gradient centrifugation (F) (*p = 0.0306). (B) The box plots show the percentage of
Lin2CD452 CXCR4+/CD34+/Nestin+ viable (7AAD negative) and dead (7AAD positive) cells using lysing buffer: note that the percentage of viable cells
is significantly higher than that of dead cells (n = 5; *p = 0.0001); and the gate shows the 7AAD negative Lin2CD452CD34+ as an example (Staining for
7AAD and Nestin is not technically possible as Nestin is an intracellular staining). (C) The box plots show the number of colonies formed by cells
isolated using lysis buffer after 14 days in culture (n = 5; *p = 0.0005). (D) Absolute count of both Lin2CD452CD34+ and Lin2CD45dimCD34+ cells
plated in CFUs. CFUs = Colony Forming Units. (–F) = negative fraction. (+F) = positive fraction.
doi:10.1371/journal.pone.0067968.g001
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Foster City, CA) with GoTaq (Promega) using primers and
conditions previously described by Guasti et al. [16].
Real-time quantitative polymerase chain reaction (qPCR) was
performed with an ABI Prism 7500 sequence detection system
(Applied Biosystems) and the QuantiTect SYBR Green PCR Kit
(Qiagen) according to the manufacturer’s instructions. PCR
reactions were set up in triplicates in 96 well plates. The
housekeeping gene GAPDH was used as an internal control to
normalize expression levels and data were analysed using the 2
2DDCT method.
Cell Culture
For colony-forming unit (CFU) assessment, all cells recovered
from –F were plated in Methylcellulose medium supplemented
with recombinant cytokines as previously described [17] and
haematopoietic colonies scored after 14 days. One million of
TNCs (containing around of 1000–2000 HSC) from positive
fraction (+F) were plated as a control.
Absolute counts of both Lin2CD452CD34+ and Lin2CD45-
dimCD34+ cells were performed as described previously [17] in
the –F fraction to estimate the number of HSC contaminants
plated.
For cell survival and growth studies cells were plated either on
Matrigel (BD Matrigel TM hESC-qualified Matrix, Cat: 354277)
or laminin (SIGMA, Cat: L2020 added to the medium conditions).
Five different culture media (A–E) were used, and their
composition is shown in Table 1. The components were
DMEM/F-12 (1:1) (GIBCO, Cat: 31330), RHB-AH (StemCells
Inc. Cat: SCS-SF-NB-01), StemSpanH SFEM (STEMCELL
TECHNOLOGIES, Cat:09600) MethoCultH GF H84434
(STEMCELL TECHNOLOGIES); B27 and N2 neuronal sup-
plements (PAA, Cat: F01-005 and F005-004, respectively); FGF-2
(PeproTech, Cat: 100–118B; or Miltenyi Biotec Cat: 130-093-
838), EGF (PeproTech, Cat: AF-100-15), Stem cell Factor
(Miltenyi Biotec, Cat: 130-093-991), Flt3-Ligand (Miltenyi Biotec,
Cat: 130-093-854). The medium was changed every 3–4 days and
cells monitored for up to one month.
Immunocytochemistry
Cell suspensions from the negative fraction were used to make
cell smears for immunocytochemistry. After smearing, cells were
fixed with 4% paraformaldehyde for 10 minutes, washed twice
with PBS, and air-dried. After incubation with the blocking buffer
cells were stained with the following primary antibodies to surface
antigens: mouse anti-SSEA-4 (Invitrogen Cat: 41–4000; 1:100),
mouse antihuman CD133 (Miltenyi Biotec, cat: 130-190-422;
1:10) and mouse anti-human CD34 (abcam Cat:ab6330; 1:100)
with cells previously blocked. Bound antibodies were detected
Figure 2. Characterization of cord blood mononuclear cells (CBMCs) isolated using the lysis protocol. (A) Debris is excluded from the
whole CBMC in an open scale using beads as a size marker (4.2 mm and 6 mm). (B) Gate set to exclude Lin+/CD41a+ cells. (C) CXCR4+ is detected in the
Lin2CD452 fraction. (D) CD34+ is detected in the Lin2CD452 and Lin2CD45dim fractions. (E) Nestin is detected in the Lin2CD452 fraction. (F)
Lin2CD45dimCD133+ is detected but CD133+ is not detected in the Lin2CD452. Events analysed: .100,000.
doi:10.1371/journal.pone.0067968.g002
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using secondary donkey anti-mouse antibody conjugated with
Alexa Flour 568 (Invitrogen Cat: 989784). Negative controls were
incubated only with the secondary antibody. Nuclei were
counterstained with Hoechst 33258 (Sigma-Aldrich). All samples
were viewed and imaged using Axiovert 135 fluorescent micro-
scope with a C14 digital camera (Jenoptik). Image collection and
analysis was performed using Openlab, Volocity (Improvision) and
ImageJ 1.44o software [18].
Statistical Analysis
All data are represented as mean 6 standard errors of the mean
(SEM) and analyzed by unpaired t test and plotted using Prism
version 5.0 (GraphPad Software, Inc.); p values ,0.05 was taken
to be significant. A minimum number of 4 samples were used for
each experiment.
Results
Recovery of the Lin2CD452 Fraction from Cord Blood
Total Nucleated Cells (TNCs) using either Lysis or Ficoll
We assessed whether recovery of the Lin2CD452 fraction
differed when lysing buffer or Ficoll density centrifugation were
used to prepare TNCs. As shown in Fig. 1A, the percentage of
Lin2CD452 cells recovered was significantly lower (p = 0.0025)
after cell isolation with Ficoll (21.7964.475 N=4) than with lysis
buffer (60.4266.044 N=10). With both procedures the main
contaminants consisted of platelets, other mature cells, and to, a
minimal extent, of Lin2CD45dimCD34+ cells. To assess the
viability of cells (on day 0) prepared with lysis buffer, 7AAD
staining followed by flow cytometry analysis was performed. More
than 80% of cells within the Lin2CD452 population were
negative for 7AAD (85.9063.453 N=5) indicating that the
majority of the cells were not apoptotic/necrotic (Fig. 1 B).
Immunophenotypic analysis of TNCs
We characterised the antigenic phenotype of the TNCs by flow
cytometry focusing on the Lin2CD452 cell fraction. Standard
flow cytometry-based protocols for HSC usually exclude events
smaller than 6 mm as this fraction is mainly composed of
erythrocytes, platelets, and cellular debris [19,20]. As previous
reports suggested that Lin2CD452 cells are smaller than HSC,
with a size between 2–7 mm [3,4,5], we applied a log scale to the
Forward scatter to including events smaller than 6 mm using beads
as size markers. When events starting from 3 mm were included
(Figure 2A), cells positive for Lin and CD41a, a specific platelet
marker, were excluded by gating (Figure 2B); expression of CD45,
CD133, CD34, CXCR4 and Nestin was assessed in the Lin2 gate
Figure 3. Characterisation of the Lin2CD452 population after isolation with magnetic columns. (A) Debris (,1 mm) is excluded from the
negative fraction. (B) Gate shows the exclusion of Lin+/CD41a+ cells as main contaminants and the gating of Lin2CD452 population. (C, D, E) CD34+,
CXCR4+ and Nestin+ are detected in the Lin2CD452 fraction. (F) CD133+ is not detected in the Lin2CD452fraction. (C, D, E, and F percentages
represent the mean from 4 different samples). Events analysed: .100,000.
doi:10.1371/journal.pone.0067968.g003
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separately in samples (Fig. 2C–F). The Lin2CD452 population
expressed CD34, CXCR4, and Nestin, but not CD133.
Characterisation of the Lin2CD452 Cell Fraction
The Lin2CD452 population was further characterized by flow
cytometry, immunocytochemistry and RT-PCR.
Flow cytometry showed that CD34, CXCR4, and Nestin
positive cells were consistently detected in all cell preparations
(n = 4; Fig. 3C–E); in contrast, detection of CD133 was a rare
event and most samples were negative (,0.03%, n= 4; Fig. 3F).
Interestingly, Nestin+ and CD34+ cells were different in size from
CXCR4 cells, as assessed by SSC and FSC (Fig. 4A). In double-
staining experiments it was found that cells positive for CXCR4
were negative for CD34 (Fig. 4C), while approximately 21% of
Nestin positive cells were also positive for CD34 (20.9767.242
N=4; Fig. 4D). Finally of note, a high proportion of events were
either very small, on the edge of the 2 mm threshold (80%), or not
stained by any antibody used; these could represent cellular debris.
The Lin2CD452 populations were separately back-gated for
SSC and FSC to compare them with the Lin2CD45dimCD34+
population using beads as size markers. The Lin2CD452 cells
were found to be smaller than Lin2CD45dimCD34+ cells by SSC
and FSC (Fig. 4A).
Expression of the pluripotent markers, SSEA-4, Sox2, and
Oct3/4, in the Lin2CD452 fraction was investigated by using flow
cytomery. SSEA-4 was expressed in 260.3498% (N=5) of the
cells and Oct3/4 in less than 1% (Fig. 5B–C). Sox2 was not found
expressed by flow cytometry (Fig. 5A). Of note, the SSEA-4
positive cells were negative for CD34 and CD133. These positive
cells, when back-gated, were similar in size (by SSC and FSC) to
the Nestin+ cells, as shown in (figure 5D).
Expression of transcripts for the pluripotent markers, SOX2,
OCT3/4, and NANOG, was assessed by RT-PCR. The
Lin2CD452 fraction expressed SOX2, OCT3/4 and weakly
NANOG (Fig. 5E). Expression of the stem cell markers, CD133
and Nestin, was assessed by RT-qPCR. Consistent with the flow
cytometry results, the CD133 transcript, which was highly
expressed in hNSC, was undetectable in the Lin2CD452 fraction.
Nestin, however, was detected (Fig. 5F–G). Nestin expression in
Figure 4. Heterogeneity of the Lin2CD452 population. (A) SSC and FSC back gate show CXCR4+, CD34+, and Nestin+ subpopulations
compared to specific size beads of 6 mm and the Lin2CD45dimCD34+ (black); they have the same range of size in FSC but are allocated differently in
SSC. (B) The box plot shows the percentage of CD34+, CXCR4+ and Nestin+ cells; note that Nestin+ cells are the larger population within the
Lin2CD452 cell fraction. (n = 4; *p,0.05/**p,0.005). (C) Gate shows that CXCR4+ cells are negative for CD34 (D) Gate shows Nestin+ CD342 and
Nestin+ CD34+ cells. (C and D percentages represent the mean from 4 different samples).
doi:10.1371/journal.pone.0067968.g004
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Lin2CD452 cells was higher than in UC-MSC, but much lower
than in hNSC.
Immunocytochemistry was used to visualize the expression of
CD34, CD133 and SSEA-4 in Lin2CD452 cells (Fig. 6A–C).
Staining for CXCR4 was not performed as it is also expressed in
most haematopoietic cells and, therefore, its presence might be
partly due contaminating cells. CD34+ cells were present in all the
samples examined (Fig. 6A–B). No CD133+ cell was observed
(data not shown), consistent with the flow cytometry and RT-
qPCR data. Only two cells positive for SSEA-4 were detected in
the 5 samples analysed (Fig. 6C). Lin2CD452 stem cells showed
high nuclear/cytoplasm ratio and a size between 6 to 10 microns
(Fig. 6A–C). Cell debris, consistent with the flow cytometry results
(Fig. 3), was present in cell fraction, as indicated by Hoechst
nuclear staining, (Figure 6B).
Survival and Growth of Lin2CD452 Cells
We tested the clonogenic potential of Lin2CD452 cells
compared with the CD45+CD34/CD133+ cells present in the
+F fraction using the CFU assay. The number of colonies was
significantly higher in TNCs from +F (101.0615.76 N=5) than in
Lin2CD452 cell cultures (8.80064.375 N=5), p= 0.0005.
Colonies originating from the Lin2CD452 fraction could be
attributed to contaminating cells with a Lin2CD45dimCD34+
phenotype (Fig. 1C and 1D).
We then tested the ability of Lin2CD452 cells to survive and
grow in different media known to be suitable for the expansion/
differentiation of embryonic-like stem cells [3,21], HUCBSC
[17,22], and hNSC [14] and on different substrates (Table 1).
Proliferation was not observed under any of the culture conditions
tested (A–E; Table 1). In culture conditions A, B, and C all cells
were dead by 15 days in culture, whereas viable remaining cells
were still present under condition D, a medium that supports
expansion of neural stem cells and E, a medium that supports
Figure 5. Expression of transcripts typical of pluripotent cells and CD133 in the Lin2CD452 population. (A–C) Expression of the
embryonic stem cell markers, SSEA-4 and OCT3/4 but not of SOX2 are detected by flow cytometry (percentage represents the mean from 5 different
samples). (D) SSC and FSC back gate shows SSEA-4+ and OCT3/4+ subpopulations compared to specific size beads of 6 mm and the
Lin2CD45dimCD34+ (black); they are in the same size range both in FSC or SSC. (E) SOX2, OCT3/4 and NANOG transcripts are detected by RT-PCR. (F
and G) Expression of Nestin and CD133 markers by qPCR in human neural (hNSC), in the Lin2CD452 fraction, and mesenchymal (MSC) stem cells.
Nestin is expressed in both Lin2CD452 cells and MSCs cells though at a much lower level than in hNSC. Note that CD133 mRNA is not detected in the
Lin2CD452 fraction.
doi:10.1371/journal.pone.0067968.g005
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expansion of human haematopoietic cells. The surviving cells in
these cultures were characterized at 2–3 weeks in culture by flow
cytometry (N= 3). As summarized in Table 2 different expression
profiles were observed in these cultures, with culture condition E
containing a higher percentage of CD34-, CD133- and CD45-
positive cells.
Discussion
We have shown here that the CD45 negative and haematopoi-
etic lineage marker negative hUCB population is heterogeneous
(Table 3) and includes a Nestin+ subpopulation not previously
described.
The Lin2CD452fraction we isolated expresses several stem cell
markers. Whereas we found a subpopulation expressing CD34
within this fraction, CD133 expression could not be detect either
by flow cytometry, RT-qPCR or immunocytochemistry. However,
when Lin2CD452cells were cultured for 2–3 weeks, a small
CD133 remaining population was detected which could possibly
have been attributed to the contaminants with Lin2CD45-
dimCD133+ cells. Whether the difference between our and other
author findings is due to different handling of the cells, or
differences between murine and human Lin2CD452 populations
is currently unclear. Lin2CD452 cells expressing the stem cell
markers CD34 and CD133, and the chemokine receptor CXCR4
were initially described in murine bone marrow [6]. Subsequently,
Lin2CD452 cells have been isolated by a number of different
groups from several animal and human sources including bone
marrow [6], cord blood [3,4,5,23], peripheral blood after severe
damage, such as stroke [24], and mammalian ovary [25].
Several groups have reported the presence of pluripotent
markers in this Lin2CD452 stem cell population. Our results
show the expression of SOX2, OCT4, and NANOG using RT-
PCR, which are similar to reports by Zuba-Surma, et al. and
Bhartiya, et al. [4,5]. However, the expression of the surface
SSEA-4 marker using flow cytometry was found in only a low
percentage (2%) of cells in contrast to the results reported by Ali
et al. [26] using a very similar isolation method. Nevertheless, the
same group has also reported the expression of pluripotent
markers by using RT-PCR.
Our Lin2CD452 isolated fraction was composed of a hetero-
geneous population expressing different stem cell markers (CD34,
CXCR4, and Nestin). With the exception of CD133, our analysis
showed that the Lin2CD452 population consistently expressed a
phenotype associated with stem cells. However, this is not a
homogenous population; the CD34+ and CXCR4+ populations
are different to each other and do not share mutual immunophe-
notype. Added to these differences, our flow cytometric analysis
has shown a third, Nestin+, population that is also negative for
CXCR4. Aproximately 20% of the Nestin positive cells were also
positive for CD34. A CD452Nestin+ population has been
described in the bone marrow by Mendez-Ferrer, et al. [27] and
could correspond to that described by Sauerzweig, et al. [9] as
small-sized nestin-positive bone marrow stem cell (SD-BMSC).
The presence of mesenchymal progenitors could account for the
presence of pluripotency markers whose expression has been
reported in mesenchymal stem cells [16]. However, more studies
are needed to clarify the relation between them.
The Lin2CD452 fraction we isolated consists of a population of
small cells with a high nuclear/cytoplasmic ratio. Our observa-
tions under the fluorescent microscope showed the cells having a
high nuclear/cytoplasmic ratio but their size was slightly bigger
Figure 6. Lin2CD452 cells show a high nuclear/cytoplasm ratio. (A) Immunocytochemistry shows small cells (!10 mm) with high nuclear
(blue)/cytoplasm ratio positive for CD34 (red). (B) Note one CD34-positive and one CD34–negative cell and an example of cell debris present in the
sample (arrow). (C) Rare SSEA-4–positive cell. Scale bars = 10 mm (A–B) and 5 mm (C).
doi:10.1371/journal.pone.0067968.g006
Table 2. Summary of Lin2CD452 stem cell markers found on
cells present after 2 weeks in the culture conditions shown.
Marker Culture condition D* Culture condition E*
SSEA-4 7.94% 61.52 6.34% 60.7543
CD34 1.35% 60.4572 4.65% 60.9699
CD133 1.19% 60.3960 10.04% 62.452
CD45 1.85% 60.6015 12.42% 61.774
Markers were assessed by flow cytometry and given as percentage of positive
cells; *n = 3.
doi:10.1371/journal.pone.0067968.t002
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than determined by flow cytometry (6–10 mm). This is consistent
with some previous findings [3,23,28]. However, unlike in some
studies, where this fraction did not seem to incorporate the DNA
stain Hoechst [5,23,25], in the study shown here, all nuclei of the
cells isolated were Hoechst-positive. Bhartiya et al suggested that
the lack of Hoechst labelling in quiescent cells was a consequence
of these cells containing euchromatin. However, this explanation
to explain this phenomenon still needs to be investigated as other
groups have described the labelling by Hoechst in quiescent
populations using immunohistochemistry [29]. Storms, et al. [30]
reported a Hoechst dye negative population of high pluripotency
and used flow cytometric sorting to select a small quiescent
population (which they named ‘‘side population’’) from bone
marrow and cord blood. It will have to be established whether
differences in Hoechst binding to the DNA of Lin2CD452 reflects
a true difference between the populations isolated in different
laboratories, or is due to differences in the handling of the cells.
Recently, Danova-Alt et al. have reported a
Lin2CD452CXCR4+ population from hUCB that lacks stem cell
characteristics and displays an aneuploid karyotype [23]. These
results are in stark contrast to previous reports [3,7,21], but similar
to the findings presented in this study, that provides a novel and
comprehensive approach to defining the function and nature of
these cells. Danova-Alt et al. however, have mostly focused on the
Lin2CD452CXCR4+/CD34+ populations, and neglected the
Hoechst negative population within the flow cytometry sorted
cells previously described by other groups [6,12,30]. In our study,
haematopoietic stem and mature cells were excluded using an
anti-biotin selection antibodies. Using this approach a population
of small Lin2CD452 cells with the lower possible number of
haematopoietic contaminants could be isolated, with the main
contaminant being platelets. These events are normally excluded
using flow cytometry-based protocols for HSC [4,19,20]. There-
fore, during our analysis a gating strategy based on that proposed
by Zuba-Surma et al. [4] was employed. This resulted in a similar
population as reported by Zuba-Surma et al. with the exception
that CD133+ cells were undetectable. This is, however, consistent
with the report by Danova-Alt et al. [23].
Previous studies have classified these cells based on their
phenotypical properties, including ‘‘embryonic-like stem cells’’
[4,5,7,23]. Here we highlight the difficulties in expanding the
Lin2CD452 stem cell population. These results are not unprec-
edented, as other groups have also reported similar problems with
the expansion of this population [3,4]. Our study has shown that
even using different conditions we were not able to expand this
fraction at all. In fact, the presence of a few cells that were able to
expand in the Methylcellulose medium with recombinant cyto-
kines and of a few cells surviving long-term in StemSpanH SFEM
could be attributed to the presence of contaminants such as
Lin2CD45dimCD34/133+cells. This result contrasts with most of
the previous reports but is consistent with the findings of Danova-
Alt et al. [23]. The presence and origin of pluripotent markers, as
well as the functional role of these cells, should be investigated
before attempting to classify them as embryonic-like cells.
Currently, the definition of non-Haematopoietic stem cells (non-
HSC) seems prudent until further studies elucidate their origin,
function and possible use in regenerative medicine.
Despite of the fact that more than 80% of Lin2CD452 cells
were 7AAD negative, it was not possible to determine whether
these cells were in an early apoptotic stage. Lin2CD452 cells have
been reported to bind Annexin V following red blood cell lysis,
though they do not subsequently undergo apoptosis [31].
Nonetheless, the presence of haematopoietic colonies in CFUs
either in –F or +F and of surviving cells in culture condition E
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could be taken as a rough indicator that cell viability was not
severely affected by lysis.
Human umbilical cord blood has both HSC and non-HSC as
several groups have demonstrated before [4,5,7,23,32]. We have
shown here that the presence of a heterogeneous population
lacking the expression of LCA and other mature haematopoietic
markers, but expressing stem cell markers such as CD34 and
CXCR4, and the tissue-committed stem cell marker Nestin, could
explain the discrepancies in the literature. These differences could
be due to the fact that diverse methods of isolation lead to the
sorting of different populations.
In conclusion, our work has described three different cell
subpopulations including Lin2CD452 Nestin+, which has not
been previously reported (Table 3) by any of the groups working
with hUCB-derived ‘‘embryonic-like cells’’ [4,5,7,23,32]. However
more research will be needed to establish the relationship between
these populations and those previously described. A better
understanding of the origin and function of this heterogeneous
Lin2CD452 stem cell population (non-HSC) is required before
considering their potential use in regenerative medicine applica-
tions.
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